Back to Search
Start Over
27237 Effect of abrocitinib vs dupilumab and placebo on patient-reported outcomes (PROs) in moderate-to-severe atopic dermatitis (AD) in JADE COMPARE
- Source :
- Journal of the American Academy of Dermatology. 85:AB133
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
Details
- ISSN :
- 01909622
- Volume :
- 85
- Database :
- OpenAIRE
- Journal :
- Journal of the American Academy of Dermatology
- Accession number :
- edsair.doi...........087564e79800f9d0be99661936890cac
- Full Text :
- https://doi.org/10.1016/j.jaad.2021.06.551